Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

INMED PHARMACEUTICALS INC. (INM)

  • Technical Exchange News
  • April 07, 2026, 02:23 UTC
  • 8
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

INM attributes changed

  • Technical Exchange News
  • April 07, 2026, 02:23 UTC
  • 7
  • 0 comments

INM attributes changed: Attr: Fin_status N -> D;

Comment Full text

DTSS attributes changed

  • Technical Exchange News
  • April 07, 2026, 02:22 UTC
  • 6
  • 0 comments

DTSS attributes changed: Attr: Fin_status N -> D;

Comment Full text

CIIT attributes changed

  • Technical Exchange News
  • April 07, 2026, 02:22 UTC
  • 8
  • 0 comments

CIIT attributes changed: Attr: Fin_status D -> N;

Comment Full text

ARTL attributes changed

  • Technical Exchange News
  • April 07, 2026, 02:21 UTC
  • 9
  • 0 comments

ARTL attributes changed: Attr: Fin_status D -> N;

Comment Full text

ARTELO BIOSCIENCES, INC. (ARTL)

  • Technical Exchange News
  • April 07, 2026, 02:21 UTC
  • 7
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

IO BIOTECH, INC. (IOBT)

  • Technical Exchange News
  • April 07, 2026, 01:51 UTC
  • 10
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

INMED PHARMACEUTICALS INC. (INM)

  • Technical Exchange News
  • April 07, 2026, 01:51 UTC
  • 13
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

ARTELO BIOSCIENCES, INC. (ARTL)

  • Technical Exchange News
  • April 07, 2026, 01:50 UTC
  • 13
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

ODYSIGHT (ODYS)

  • Technical Exchange News
  • April 06, 2026, 14:13 UTC
  • 11
  • 0 comments

ODYSIGHT (ODYS) was added to the list of traded instruments on TASE exchange

Comment Full text
  • Previous
  • 58
  • 59
  • 60
  • 61
  • 62
  • Next

Search

News categories

  • Technical Exchange News(12261)
  • Event(6229)
  • SEC News(265726)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155239)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin